Published July 28, 2025 | Version v1
Other Open

Are donanemab or lecanemab effective for the treatment of Alzheimer's disease?

Authors/Creators

  • 1. Tripdatabase

Description

Donanemab and lecanemab have shown promise in slowing cognitive decline in early Alzheimer's disease, but they also present risks such as ARIA. Further research is needed to assess their long-term safety and efficacy.

Files

b9ae3945-e34e-4499-a81b-cf41a219253e.pdf

Files (18.4 kB)

Name Size Download all
md5:eeaad2c0df8c1dcbf9e97a1d1e31a78a
18.4 kB Preview Download

Additional details

Related works

Is identical to
https://www.tripdatabase.com/ask/donanemab-lecanemab-effective-treatment-alzheimers-b9ae3945-e34e-4499-a81b-cf41a219253e (URL)